These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23954847)

  • 21. Abuse of inhalants: a review.
    Dinwiddie SH
    Addiction; 1994 Aug; 89(8):925-39. PubMed ID: 7950851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of volatile substance abuse: a case report and a literature review.
    al-Alousi LM
    Med Sci Law; 1989 Jul; 29(3):189-208. PubMed ID: 2671576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volatile substance abuse.
    Flanagan RJ; Ives RJ
    Bull Narc; 1994; 46(2):49-78. PubMed ID: 7866398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medico-legal implications of toluene abuse and toxicity. Review of cases along with blood concentrations.
    Pelletti G; Rossi F; Garagnani M; Barone R; Roffi R; Pelotti S
    Leg Med (Tokyo); 2018 Sep; 34():48-57. PubMed ID: 30172242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurocircuitry of addiction: an overview.
    Feltenstein MW; See RE
    Br J Pharmacol; 2008 May; 154(2):261-74. PubMed ID: 18311189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated toluene exposure alters the synaptic transmission of layer 5 medial prefrontal cortex.
    Cruz SL; Torres-Flores M; Galván EJ
    Neurotoxicol Teratol; 2019; 73():9-14. PubMed ID: 30826315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volatile substance and other drug abuse inhalation in Spain.
    Ramón MF; Ballesteros S; Martinez-Arrieta R; Torrecilla JM; Cabrera J
    J Toxicol Clin Toxicol; 2003; 41(7):931-6. PubMed ID: 14705837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of addiction.
    Clay SW; Allen J; Parran T
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse pattern of gestational toluene exposure and early postnatal development in rats.
    Bowen SE; Batis JC; Mohammadi MH; Hannigan JH
    Neurotoxicol Teratol; 2005; 27(1):105-16. PubMed ID: 15681125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of chromatin states by drugs of abuse.
    Walker DM; Cates HM; Heller EA; Nestler EJ
    Curr Opin Neurobiol; 2015 Feb; 30():112-21. PubMed ID: 25486626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol and basal ganglia circuitry: Animal models.
    Lovinger DM; Alvarez VA
    Neuropharmacology; 2017 Aug; 122():46-55. PubMed ID: 28341206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse.
    Chen BT; Hopf FW; Bonci A
    Ann N Y Acad Sci; 2010 Feb; 1187():129-39. PubMed ID: 20201850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interhemispheric insular and inferior frontal connectivity are associated with substance abuse in a psychiatric population.
    Viswanath H; Velasquez KM; Savjani R; Molfese DL; Curtis K; Molfese PJ; Eagleman DM; Baldwin PR; Frueh BC; Fowler JC; Salas R
    Neuropharmacology; 2015 May; 92():63-8. PubMed ID: 25592214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volatile substance abuse: a review of possible long-term neurological, intellectual and psychiatric sequelae.
    Ron MA
    Br J Psychiatry; 1986 Mar; 148():235-46. PubMed ID: 3013354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse.
    Willuhn I; Wanat MJ; Clark JJ; Phillips PE
    Curr Top Behav Neurosci; 2010; 3():29-71. PubMed ID: 21161749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of long-term depression by dopamine in the mesolimbic system.
    Thomas MJ; Malenka RC; Bonci A
    J Neurosci; 2000 Aug; 20(15):5581-6. PubMed ID: 10908594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of 1,1,1-trichloroethane (methylchloroform) in industrial operations: the neurotoxicity risk].
    Fernicola C; Govoni S; Coniglio L; Daniele E; Trabucchi M
    Med Lav; 1991; 82(1):38-49. PubMed ID: 1865846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological substrates of addiction.
    Joffe ME; Grueter CA; Grueter BA
    Wiley Interdiscip Rev Cogn Sci; 2014 Mar; 5(2):151-171. PubMed ID: 24999377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FEATURES OF LIMBIC-NEOCORTICAL AND MONOAMINERGIC CORRELATIONS IN THE DEVELOPMENT OF WITHDRAWAL SYNDROME OF INHALATIONS OF VAPORS OF ORGANIC SOLVENT «646» IN RATS.
    Levicheva NA; Titkova AM
    Fiziol Zh (1994); 2016; 62(3):60-5. PubMed ID: 29569887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.